logo
[breadcrumb_custom]

Tag: BIOLASE Inc.

Industry

BIOL’s Financial Health: Exploring Biolase Inc’s Debt-to-Equity Ratio of 1.79

Biolase Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $47.10 on 04/19/23, with the lowest value being $0.13 on 03/08/24. 52-week price history of BIOL Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Biolase Inc’s current trading price is -99.64% away from its 52-week high, while its distance from the 52-week low is 35.33%. The stock’s price range during this period has fluctuated between $0.13 and $47.10. Shares of the company, which operates in the Healthcare sector,

ALXO Stock
Stock

BIOL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect?

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -84.35% this year. Over the last six months, there has been a stronger performance of -90.71%. The price of BIOL fallen by 23.06% during the last 30 days period. For the last 5-days stocks have improved 9.54%. The market performance of Biolase Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at

News

Biolase Inc (BIOL) Stock: A Year of Highs and Lows in the Market

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Biolase Inc’s current trading price is -99.60% away from its 52-week high, while its distance from the 52-week low is 50.28%. The stock’s price range for this time frame has been between $0.13 and $47.10. The trading volume of the company’s shares in the Healthcare reached around 6.36 million for the day, which was evidently higher than the average daily volume of 5.03 million over the last three months. Biolase Inc’s stock market performance has been somewhat irregular. The

CSCO Stock
Industry

Biolase Inc (BIOL) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Biolase Inc’s current trading price is -99.64% away from its 52-week high, while its distance from the 52-week low is 35.89%. The stock’s price range over this period has fluctuated between $0.13 and $47.10. The company, operating within the financial sector, had a trading volume of approximately 8.88 million for the day, which was noticeably higher than the average daily share volume of 4.9 million over the last 3 months. Biolase Inc’s market performance has been unstable

Stock

Biolase Inc (BIOL) Stock: A Year of Declines and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Biolase Inc’s current trading price is -99.62% away from its 52-week high, while its distance from the 52-week low is 43.33%. The stock’s price range for this period has been between $0.13 and $47.10 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 130.4 million for the day, a number notably higher than the average daily volume of 2.75 million over the last three months. Biolase Inc’s market performance has been unstable in

News

BIOL’s Market Whiplash: -86.71% YTD Decline, -0.47% Plunge in 30 Days

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -86.71% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -92.87%. Over the past 30 days, the price of BIOL has leaped by -0.47%. And in the last five days, it has surged by 8.04%. Biolase Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $47.10 on 04/19/23, while the

TOST Stock
News

Biolase Inc (BIOL) Stock: The Story of a 52-Week Stock Range

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Biolase Inc’s current trading price is -99.73% away from its 52-week high, while its distance from the 52-week low is -2.27%. The stock’s price range during this period has varied between $0.13 and $48.40. The company, active in the Healthcare sector, saw a trading volume of around 3.81 million for the day, considerably higher average daily volume of 2.04 million observed over the last three months. Biolase Inc had a pretty Dodgy run when it

HCCC Stock
Finance

Biolase Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio

Biolase Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $52.00 on 03/03/23, while the lowest value for the same period was recorded at $0.13 on 02/14/24. 52-week price history of BIOL Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Biolase Inc’s current trading price is -99.70% away from its 52-week high, while its distance from the 52-week low is 19.32%. The stock’s price range during the 52-week period has remained between $0.13 and $52.00.

THMO
Stock

Biolase Inc (BIOL) Stock: Uncovering 52-Week Market Trends

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Biolase Inc’s current trading price is -99.71% away from its 52-week high, while its distance from the 52-week low is 12.50%. The stock’s price range for this period has been between $0.13 and $52.00 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.39 million for the day, a number notably higher than the average daily volume of 1.45 million over the last three months. Biolase Inc experienced a rather shaky stock market